HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000031 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 24, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,369
Total Value
$73,606.26
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, CHIEF OPERATING OFFICER | Common Stock | โ | Feb 20, 2026 | Exercise/Conversion | 2,666 | $0.00 | $0.00 | 15,403 | Direct | โ | View Details | |
SVP, CHIEF OPERATING OFFICER | Common Stock | โ | Feb 20, 2026 | Tax Withholding | 1,037 | $70.98 | $73,606.26 | 14,366 | Direct | โ | View Details | |
SVP, CHIEF OPERATING OFFICER | Restricted Stock Units | Derivative | Feb 20, 2026 | Exercise/Conversion | 2,666 | $0.00 | $0.00 | 7,998 | Direct | โ | View Details |